Expression characteristics of transforming growth factor-beta1 in human skin at different development stages of gestation

OBJECTIVE: To investigate gene expression of transforming growth factor-beta(1) (TGF-beta(1)) and its two upstream signalling factors (smad2 and smad3) in fetal skin at different gestational ages and postnatal skin and its potential biological significance

Bibliographische Detailangaben
Veröffentlicht in:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue. - 1998. - 16(2004), 4 vom: 06. Apr., Seite 206-9
1. Verfasser: Chen, Wei (VerfasserIn)
Weitere Verfasser: Fu, Xiao-bing, Ge, Shi-li, Sun, Tong-zhu, Jiang, Du-yin, Zhou, Gang, Sheng, Zhi-yong
Format: Aufsatz
Sprache:Chinese
Veröffentlicht: 2004
Zugriff auf das übergeordnete Werk:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue
Schlagworte:English Abstract Journal Article Research Support, Non-U.S. Gov't Actins DNA-Binding Proteins RNA, Messenger SMAD2 protein, human Smad2 Protein TGFB1 protein, human Trans-Activators mehr... Transforming Growth Factor beta Transforming Growth Factor beta1
LEADER 01000caa a22002652 4500
001 NLM14765114X
003 DE-627
005 20250205115129.0
007 tu
008 231223s2004 xx ||||| 00| ||chi c
028 5 2 |a pubmed25n0492.xml 
035 |a (DE-627)NLM14765114X 
035 |a (NLM)15068708 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Chen, Wei  |e verfasserin  |4 aut 
245 1 0 |a Expression characteristics of transforming growth factor-beta1 in human skin at different development stages of gestation 
264 1 |c 2004 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 07.10.2004 
500 |a Date Revised 15.11.2006 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a OBJECTIVE: To investigate gene expression of transforming growth factor-beta(1) (TGF-beta(1)) and its two upstream signalling factors (smad2 and smad3) in fetal skin at different gestational ages and postnatal skin and its potential biological significance 
520 |a METHODS: Fetal skin samples of human embryo were obtained from spontaneous abortions at different gestational ages ranging from 13 to 32 weeks, and also skin collected from patients undergoing plastic surgery. After morphological characteristics of skin at different developmental stages were examined histologically, gene expressions of TGF-beta(1), smad2 and smad3 in skin specimens at different developmental stages were examined with reverse transcription-polymerase chain reaction analysis (RT-PCR) 
520 |a RESULTS: Gene expression of TGF-beta(1), smad2 and smad3 could all be detected in fetal skin and skin after birth. In skin from early gestational fetus, gene expressions of TGF-beta(1) and smad2 were weak. Along with advance in gestational age, gene expression of these two genes in skin became progressively stronger. In skin from late gestational fetus and skin after birth, the transcription contents of these two genes were significantly increased compared with early gestation fetus (P<0.05). On the contrary, gene expression of smad3 was apparently higher in younger fetal skin versus elder compared with that of late fetal skin (P<0.05). In skins after birth, the levels of smad3 gene expression were elevated to the level similar to that in early gestational fetal skin 
520 |a CONCLUSION: The signal pathway mediated by TGF-beta(1) might be involved in regulating development of the skin at embryonic stage and in designating cetaceous structure and function, and also in wound healing after birth. The relative lack in expression of TGF-beta(1) and smad2 genes in skins from younger fetuses might contribute to fetal scar-less healing, in which the role of smad3 needs to be further investigated 
650 4 |a English Abstract 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Actins  |2 NLM 
650 7 |a DNA-Binding Proteins  |2 NLM 
650 7 |a RNA, Messenger  |2 NLM 
650 7 |a SMAD2 protein, human  |2 NLM 
650 7 |a Smad2 Protein  |2 NLM 
650 7 |a TGFB1 protein, human  |2 NLM 
650 7 |a Trans-Activators  |2 NLM 
650 7 |a Transforming Growth Factor beta  |2 NLM 
650 7 |a Transforming Growth Factor beta1  |2 NLM 
700 1 |a Fu, Xiao-bing  |e verfasserin  |4 aut 
700 1 |a Ge, Shi-li  |e verfasserin  |4 aut 
700 1 |a Sun, Tong-zhu  |e verfasserin  |4 aut 
700 1 |a Jiang, Du-yin  |e verfasserin  |4 aut 
700 1 |a Zhou, Gang  |e verfasserin  |4 aut 
700 1 |a Sheng, Zhi-yong  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue  |d 1998  |g 16(2004), 4 vom: 06. Apr., Seite 206-9  |w (DE-627)NLM098227793  |x 1003-0603  |7 nnns 
773 1 8 |g volume:16  |g year:2004  |g number:4  |g day:06  |g month:04  |g pages:206-9 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 16  |j 2004  |e 4  |b 06  |c 04  |h 206-9